Showing results (141-150 of 202) with videos related to
Sort By:
Pageof 21
Immunobiology|January 9, 2013
Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trialMarina Harutyunyan, Jens P Gøtze, Per Winkel, et al.Stem Cell Research & Therapy|June 11, 2022
Adipose-derived stromal cells increase the formation of collagens through paracrine and juxtacrine mechanisms in a fibroblast co-culture model utilizing macromolecular crowdingRebekka Harary Søndergaard, Lisbeth Drozd Højgaard, Alexander Lynge Reese-Petersen, et al.European Journal of Preventive Cardiology|February 14, 2018
Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudySigne H Nielsen, Naja D Mygind, Marie M Michelsen, et al.Journal of Clinical Epidemiology|January 20, 2012
Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart diseaseErik Kjoller, Jorgen Hilden, Per Winkel, et al.Clinical Physiology and Functional Imaging|October 8, 2020
Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudyDaria F Bechsgaard, Jens D Hove, Marie M Michelsen, et al.Scandinavian Cardiovascular Journal : SCJ|April 14, 2011
Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory anginaTina Friis, Mandana Haack-Sørensen, Anders B Mathiasen, et al.Journal of the American College of Cardiology|April 6, 2005
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trialJens Kastrup, Erik Jørgensen, Andreas Rück, et al.European Heart Journal|March 10, 2009
High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery diseaseJens Kastrup, Julia S Johansen, Per Winkel, et al.Clinical Chemistry and Laboratory Medicine|August 12, 2021
A screening method to spot biomarkers that may warn of serious events in a chronic disease - illustrated by cardiological CLARICOR trial dataPer Winkel, Jørgen Hilden, Janus Christian Jakobsen, et al.Journal of the American Heart Association|March 3, 2020
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery DiseaseJakob Schroder, Janus Christian Jakobsen, Per Winkel, et al.Pageof 21